INDEPENDENT THINKING.
SHARED UNDERSTANDING.International edition · Correspondents across India and around the world
RationalTimes●
A little less noise.
A little more perspective.
Join our media house
BREAKING
VerifiedGold falls as upcoming Fed rate hike weighs VerifiedChalmers says spending will be cut in mid-year update 'but not too much' VerifiedWegovy Reduces BMI in Kids With Obesity as Young as 6 VerifiedThaksin loses bid to halt seizure of assets VerifiedSirens activated at Iraq’s Khor Mor gas field after drone overflight, sources say ClimateCOP31 climate talks open in Antalya, Türkiye, on 9 November USAmericans vote in the midterm elections on 3 November TechnologyNorth Korea-linked hackers steal about $6.4 billion from Binance in the biggest crypto theft on record, analysts say WorldSpain mourns after a high-speed train ploughs into a stationary train near Toledo, killing at least 68 WorldIsrael’s election ends without a clear winner as exit polls leave both blocs short of a majority WorldSaudi Arabia intercepts Houthi missiles and drones as Egypt’s parliament backs military support PoliticsLula wins Brazil’s presidential runoff as Flávio Bolsonaro concedes
Verified · 2 outletsIndia

Biocon Gets US FDA Approval For Pebrilzo Breast Cancer Drug, Plans US Launch In 2028

Headline via Free Press Journal · first report 16 Nov, 18:34 IST, latest 17 Nov, 02:26 IST

The US Capitol, Washington
Representational image · The US Capitol, Washington · Martin Falbisoner / Wikimedia Commons, CC BY-SA 3.0

What we know

2 independent news organisations have reported this story. The first report we saw came from Free Press Journal at 16 Nov, 18:34 IST; the latest is from STAT at 17 Nov, 02:26 IST. Rational Times has not independently confirmed the details: read each report through the links below.

StatusVerified
Reported by2 news organisations
First report16 Nov, 18:34 IST
Latest report17 Nov, 02:26 IST
DeskIndia

What the reports sayEach newsroom’s own summary of its report, from its feed

The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.

Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.

The reports2 reports

Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake

Read nextThe biggest stories right now